Clinical Trials
45 trialsClinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
GC Cell Corporation
RESECT
Hospices Civils de Lyon
MIRAGE
European Organisation for Research and Treatment of Cancer - EORTC
CSCRGBM
Cordgenics, LLC
CheckMate 143
Bristol-Myers Squibb
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Denovo Biopharma LLC
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
Canadian Cancer Trials Group
Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
Henry Ford Health System
Intellance1
AbbVie
FLEGME
Rennes University Hospital
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Wake Forest University Health Sciences
Bevacizumab and Lomustine for Recurrent GBM
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Radiation Therapy Oncology Group
ASTER
Assistance Publique - Hôpitaux de Paris
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
Radiation Therapy Oncology Group
Enzastaurin Versus Lomustine in Glioblastoma
Eli Lilly and Company
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
National Cancer Institute (NCI)
GLOBE
Vascular Biogenics Ltd. operating as VBL Therapeutics
ACT IV
Celldex Therapeutics
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
Hoffmann-La Roche
CeTeG
University Hospital, Bonn
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)
Merck Sharp & Dohme LLC
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
NovoCure Ltd.
REGAL
AstraZeneca
Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
National Institutes of Health Clinical Center (CC)
Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
King Faisal Specialist Hospital & Research Center
Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
International Atomic Energy Agency
CENTRIC
EMD Serono
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
National Cancer Institute (NCI)
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
Radiation Therapy Oncology Group
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
SWOG Cancer Research Network
Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
European Organisation for Research and Treatment of Cancer - EORTC
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
European Organisation for Research and Treatment of Cancer - EORTC
SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Pfizer
Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)
NovoCure Ltd.
Methusalem
Heidelberg University
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
INSYS Therapeutics Inc
Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme
National Cancer Institute (NCI)
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
Novartis
High Light and Low Light Dose PDT in Glioma
Case Comprehensive Cancer Center
Chloroquine for Treatment of Glioblastoma Multiforme
National Institute of Neurology and Neurosurgery, Mexico
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Pfizer
Radiotherapy for Malignant Astrocytomas in the Elderly
Assistance Publique - Hôpitaux de Paris